Log In
BCIQ
Print this Print this
 

ABY-016

  Manage Alerts
Collapse Summary General Information
Company amp biosimilars AG
DescriptionUndisclosed biosimilar
Molecular Target
Mechanism of ActionAntibody; Biosimilar
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat undisclosed immunological condition(s)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today